These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17121432)

  • 1. Wnt-1 is dominant over neu in specifying mammary tumor expression profiles.
    Huang S; Podsypanina K; Chen Y; Cai W; Tsimelzon A; Hilsenbeck S; Li Y
    Technol Cancer Res Treat; 2006 Dec; 5(6):565-71. PubMed ID: 17121432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of expression profiles of metastatic versus primary mammary tumors in MMTV-Wnt-1 and MMTV-Neu transgenic mice.
    Huang S; Chen Y; Podsypanina K; Li Y
    Neoplasia; 2008 Feb; 10(2):118-24. PubMed ID: 18283333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype.
    Podsypanina K; Li Y; Varmus HE
    BMC Med; 2004 Jun; 2():24. PubMed ID: 15198801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.
    Huang S; Li Y; Chen Y; Podsypanina K; Chamorro M; Olshen AB; Desai KV; Tann A; Petersen D; Green JE; Varmus HE
    Genome Biol; 2005; 6(10):R84. PubMed ID: 16207355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.
    Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S
    Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.
    Liu JC; Deng T; Lehal RS; Kim J; Zacksenhaus E
    Cancer Res; 2007 Sep; 67(18):8671-81. PubMed ID: 17875707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of cancer progression reveals intrinsic regulation of transforming growth factor-beta signaling in ErbB2/Neu-induced tumors from transgenic mice.
    Landis MD; Seachrist DD; Montañez-Wiscovich ME; Danielpour D; Keri RA
    Oncogene; 2005 Aug; 24(33):5173-90. PubMed ID: 15897883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. neu/ERBB2 cooperates with p53-172H during mammary tumorigenesis in transgenic mice.
    Li B; Rosen JM; McMenamin-Balano J; Muller WJ; Perkins AS
    Mol Cell Biol; 1997 Jun; 17(6):3155-63. PubMed ID: 9154814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
    Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
    Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Notch1 in the development of mouse mammary tumors.
    Diévart A; Beaulieu N; Jolicoeur P
    Oncogene; 1999 Oct; 18(44):5973-81. PubMed ID: 10557086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic mice.
    Jabrane-Ferrat N; Campbell MJ; Esserman LJ; Peterlin BM
    Cancer Gene Ther; 2006 Nov; 13(11):1002-10. PubMed ID: 16841083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
    Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
    Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas.
    Schroeder JA; Adriance MC; McConnell EJ; Thompson MC; Pockaj B; Gendler SJ
    J Biol Chem; 2002 Jun; 277(25):22692-8. PubMed ID: 11950845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of mouse mammary tumour virus (MMTV)/neu transgenic mice to identify genes collaborating with the c-erbB-2 oncogene in mammary tumour development.
    Jolicoeur P; Bouchard L; Guimond A; Ste-Marie M; Hanna Z; Dievart A
    Biochem Soc Symp; 1998; 63():159-65. PubMed ID: 9513720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inhibition of MMTV-neu and MMTV-wnt1 induced mammary oncogenesis by RARalpha agonist AM580.
    Lu Y; Bertran S; Samuels TA; Mira-y-Lopez R; Farias EF
    Oncogene; 2010 Jun; 29(25):3665-76. PubMed ID: 20453882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor positivity in mammary tumors of Wnt-1 transgenic mice is influenced by collaborating oncogenic mutations.
    Zhang X; Podsypanina K; Huang S; Mohsin SK; Chamness GC; Hatsell S; Cowin P; Schiff R; Li Y
    Oncogene; 2005 Jun; 24(26):4220-31. PubMed ID: 15824740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt5a suppresses tumor formation and redirects tumor phenotype in MMTV-Wnt1 tumors.
    Easter SL; Mitchell EH; Baxley SE; Desmond R; Frost AR; Serra R
    PLoS One; 2014; 9(11):e113247. PubMed ID: 25401739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice.
    Ritland SR; Rowse GJ; Chang Y; Gendler SJ
    Cancer Res; 1997 Aug; 57(16):3520-5. PubMed ID: 9270023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Limb-Bud-and-Heart (LBH) attenuates mammary hyperplasia and tumor development in MMTV-Wnt1 transgenic mice.
    Ashad-Bishop K; Garikapati K; Lindley LE; Jorda M; Briegel KJ
    Biochem Biophys Res Commun; 2019 Jan; 508(2):536-542. PubMed ID: 30509497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitor.
    Pfefferle AD; Darr DB; Calhoun BC; Mott KR; Rosen JM; Perou CM
    Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31213486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.